Treace Medical Concepts (TMCI) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 19, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by May 18, 2026.

Voting matters and shareholder proposals

• Election of three directors: Lance A. Berry, Elizabeth S. Hanna, and Jane E. Kiernan, with board recommending a vote in favor.

• Advisory, non-binding vote on executive compensation, with board recommending approval.

• Ratification of Grant Thornton LLP as independent auditor for fiscal year ending December 31, 2026, recommended by the board.

• Provision for other business to be addressed as may properly come before the meeting.

Board of directors and corporate governance

• Board nominees include experienced professionals from diverse backgrounds.

• Board provides recommendations on all voting items to guide shareholder decisions.